José-Ángel Raposo-Puglia

5PUBLICATIONS
53CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma.

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Oct 13, 2025
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua

|Dec 17, 2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

Susana Vives, David Quintela, Mireia Morgades

|Feb 23, 2024
Risk Factors and Environmental Preventive Actions for Aspergillosis in Patients with Hematological Malignancies.

Daniel Raposo Puglia, José Ángel Raposo Puglia, Emilio García-Cabrera

Pageof 1

Frequent Collaborators

2 joint publications

Maria José Calasanz

2 joint publications

Jesús-Lorenzo Algarra

2 joint publications

Mireia Morgades

2 joint publications

Juan Miguel Bergua Burgues